Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Hims, Block, and NRG Just Launched Huge Stock Buybacks: https://www.marketbeat.com/logos/articles/med_20251124124631_hims-block-and-nrg-just-launched-huge-stock-buybac.png
Hims, Block, and NRG Just Launched Huge Stock Buybacks

Several big-name stocks just announced notable increases to their share buyback programs. These actions signal confidence, indicating that these companies' management teams may see value in their

Alico (ALCO) Reports Q4 Loss, Beats Revenue Estimates
Alico (ALCO) Reports Q4 Loss, Beats Revenue Estimates

Alico (ALCO) came out with a quarterly loss of $1.1 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to earnings of $0.19 per share a year ago. These figures are

Semtech (SMTC) Surpasses Q3 Earnings and Revenue Estimates
Semtech (SMTC) Surpasses Q3 Earnings and Revenue Estimates

Semtech (SMTC) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.26 per share a year ago. These figures

Zoom Communications (ZM) Q3 Earnings and Revenues Surpass Estimates
Zoom Communications (ZM) Q3 Earnings and Revenues Surpass Estimates

Zoom Communications (ZM) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.38 per share a year ago. These

PennantPark (PFLT) Meets Q4 Earnings Estimates
PennantPark (PFLT) Meets Q4 Earnings Estimates

PennantPark (PFLT) came out with quarterly earnings of $0.28 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.32 per share a year ago. These figures are

PennantPark (PNNT) Lags Q4 Earnings and Revenue Estimates
PennantPark (PNNT) Lags Q4 Earnings and Revenue Estimates

PennantPark (PNNT) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.22 per share a year ago. These

Agilent Technologies (A) Matches Q4 Earnings Estimates
Agilent Technologies (A) Matches Q4 Earnings Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.59 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.46 per share a year ago. These figures are

Keysight (KEYS) Surpasses Q4 Earnings and Revenue Estimates
Keysight (KEYS) Surpasses Q4 Earnings and Revenue Estimates

Keysight (KEYS) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.85 per share. This compares to earnings of $1.65 per share a year ago. These figures

Fluence Energy, Inc. (FLNC) Matches Q4 Earnings Estimates
Fluence Energy, Inc. (FLNC) Matches Q4 Earnings Estimates

Fluence Energy, Inc. (FLNC) came out with quarterly earnings of $0.13 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.34 per share a year ago. These figures

Central Garden (CENT) Reports Q4 Loss, Beats Revenue Estimates
Central Garden (CENT) Reports Q4 Loss, Beats Revenue Estimates

Central Garden (CENT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago. These figures

Central Garden (CENTA) Reports Q4 Loss, Tops Revenue Estimates
Central Garden (CENTA) Reports Q4 Loss, Tops Revenue Estimates

Central Garden (CENTA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago. These figures

Woodward (WWD) Q4 Earnings and Revenues Beat Estimates
Woodward (WWD) Q4 Earnings and Revenues Beat Estimates

Woodward (WWD) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $1.41 per share a year ago. These figures

Blue Bird (BLBD) Surpasses Q4 Earnings and Revenue Estimates
Blue Bird (BLBD) Surpasses Q4 Earnings and Revenue Estimates

Blue Bird (BLBD) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.77 per share a year ago. These figures

Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3: https://www.marketbeat.com/logos/articles/med_20251124110747_retail-earnings-roundup-walmart-scores-target-slum.jpg
Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3

Mid-November marked the Q3 earnings cycle for many of the world’s biggest retail stocks, including grocery store giants and home improvement heavyweights. Three standouts—Walmart, Target, and

Top Stock Reports for Alphabet, Roche & RTX: https://staticx-tuner.zacks.com/images/articles/main/3f/12266.jpg
Top Stock Reports for Alphabet, Roche & RTX

Monday, November 24, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet

Buffett Loves Japan. Should You?
Buffett Loves Japan. Should You?
  • (0:50) - What Should Investors Know About Japan's New Prime Minister And Their Policies
  • (6:25) - What Is Currently Driving Japan’s Equity Rally?
  • (13:00) - ETFs Investors Should Consider When
JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook: https://www.marketbeat.com/logos/articles/med_20251124140759_jpmorgan-and-goldman-upgrade-mp-materials-amid-def.png
JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook

MP Materials (NYSE: MP) is not without its risks, but the risks are minimal compared to the opportunity.

The rare-earth play is gaining renewed investor attention after receiving multiple analyst

Top Stock Picks for Week of November 24, 2025
Top Stock Picks for Week of November 24, 2025

Apple’s (AAPL) business primarily runs around its flagship iPhone. Apple is benefiting from strong growth in Services revenues. The company now has more than 1 billion paid subscribers across its

Why Circle Stock Is Falling—and Why Some Analysts See Big Upside: https://www.marketbeat.com/logos/articles/med_20251124113402_why-circle-stock-is-fallingand-why-some-analysts-s.jpg
Why Circle Stock Is Falling—and Why Some Analysts See Big Upside

Circle Internet Group (NYSE: CRCL), the fintech best known as the issuer of the stablecoin USDC, has been on a tumultuous share price path since going public in June.

The stock quickly ballooned

Pure-Play vs Big Tech in Quantum: How IBM, NVDA, IONQ Stand at '25 End
Pure-Play vs Big Tech in Quantum: How IBM, NVDA, IONQ Stand at '25 End

In 2025, the quantum-computing industry gained serious momentum. Private and public players accelerated both hardware development and policy support. Companies like IonQ IONQ, D-Wave Quantum QBTS

NVIDIA Nears Buy Zone as Rumors Swirl About China Chip Deal: https://www.marketbeat.com/logos/articles/med_20251124084021_chart-nvda-11242025.png
NVIDIA Nears Buy Zone as Rumors Swirl About China Chip Deal

There is hope that NVIDIA (NASDAQ: NVDA) will soon be selling its H200 chips to China.

Bloomberg broke a story in which sources close to the inside let it be known that the possibility was on

Why Are Stocks a Strong Option in Private Wealth Management?
Why Are Stocks a Strong Option in Private Wealth Management?
Photo by Yorgos Ntrahas on Unsplash [access: 22.11.2025]Private wealth management is an essential financial service for individuals and families who need help managing their wealth. It involves
Strategy Shares Slide 41% YTD: Is Holding the Best Move Now?
Strategy Shares Slide 41% YTD: Is Holding the Best Move Now?

Strategy MSTR shares have plunged 41.1% year to date (YTD), underperforming the broader Zacks Finance sector’s growth of 11.3% and the Zacks Financial- Miscellaneous Services industry’s decline of

BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study
BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study

Bayer AG BAYRY announced that pipeline candidate asundexian met primary efficacy and safety endpoints in late-stage OCEANIC-STROKE Study in secondary stroke prevention.

Results from the study showed

JBLU Expands Gateway Program to Build Aircraft Maintenance Workforce
JBLU Expands Gateway Program to Build Aircraft Maintenance Workforce

JetBlue Airways' JBLU proactive, strategic initiative to secure the next generation of technical talent comes through the launch of Gateway University – Tech Ops. With this move, the airline is not